Postoperatif pnömonide prognoz

Literatürdeki prognoz verileri postoperatif pnömoniden çok hastane kökenli pnömoni (HKP) ve ventilatör ilişkili pnömoniye (VİP) aittir. HKP ile ilişkili mortalitenin % 33-50 arasında olduğu, yoğun bakımda VİP tanılı hastalarda mortalitenin de 1.7 ile 4.4 kat daha fazla olduğu bildirilmiştir. Cerrahi hastalarda pnömoniyle ilişkilendirilen mortalite ise % 10-18 arasındadır. Bu hastalarda sigara içme öyküsü, düşük albümin düzeyi, preoperatif devrede uzun süre hastanede yatış, torasik ve üst abdomen operasyonları postoperatif pnömoni riskini artıran faktörlerdir. Postoperatif pnömoni için geliştirilen preoperatif risk indeksinin yüksek risk taşıyan hastaların belirlenmesinde yararlı olduğu bildirilmiştir. Pnömoniye bakteremi eşlik ederse, etken Pseudomonas aeruginosa ve Staphylococcus aureus ise, APACHE II skoru yüksekse, organ yetmezliği gelişirse mortalite artmaktadır. *25.ANKEM Antibiyotik ve Kemoterapi Kongresi, Yatay İnteraktif Kurs 1C sunularından (28 Nisan-02 Mayıs 2010, Kuzey Kıbrıs Türk Cumhuriyeti)

Prognosis in Postoperative Pneumonia

Data about prognosis in the literature is usually about hospital acquired pneumonia (HAP) and ventilator associated pneumonia (VAP) rather than postoperative pneumonia. It was reported that mortality in HAP was between 33-50 % and VAP in intensive care units increased mortality 1.7-4.4 times. Pneumonia related mortality in postoperative patients is between 10-18 %. In these patients, the factors increasing risk of postoperative pneumonia are smoking history, low albumin level, prolonged preoperative hospitalization, thoracic and upper abdominal surgery. It was reported that preoperative risk index for postoperative pneumonia was useful in determination of high risk patients. The factors increasing mortality are presence of bacteremia, Pseudomonas aeruginosa and Staphylococcus aureus pneumonia, high APACHE II score and presence of organ failure.

___

  • 1. Allou N, Kermarrec N, Muller C et al: Risk factors and prognosis of post-operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery, J Antimicrob Chemother 2010;65(4): 806-7.
  • 2. Arozullah AM, Khuri SF, Henderson WG et al: Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery, Ann Intern Med 2001;135(10):847-57.
  • 3. Baker AM, Meredith J, Haponik EF: Pneumonia in intubated trauma patients: Microbiology and outcomes, Am J Respir Crit Care Med 1996;153(1): 343-9.
  • 4. Carlet J: Dying from or with a nosocomial pneumonia in the intensive care unit? Crit Care Med 2001;29(12):2392-4.
  • 5. Chastre J, Trouillet JL, Vuagnet A et al: Nosocomial pneumonia in patients with acute respiratory distress syndrome, Am J Respir Crit Care Med 1998;157(4 Pt 1):1165-72.
  • 6. Connelly SM, Trinh JV, Johnson MD et al: Mortality and time to extubation in severe hospital-acquired pneumonia, Am J Infect Control 2009;37(2):143-9.
  • 7. Croce MA, Fabian TC, Waddle-Smith L et al: Utility of Gram’s stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study, Ann Surg 1998;227(5):743-55.
  • 8. Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Pieper CF, Rutala WA: Risk factors for nosocomial pneumonia: comparing adult critical-care populations, Am J Respir Crit Care Med 1996; 153(1):158-62.
  • 9. D’Amico R, Pifferi S, Leonetti C et al: Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials, BMJ 1998;316(7140):1275-85.
  • 10. Dupont H, Montravers P, Gauzit R, Veber B, Pouriat J-L, Martin C, Club d’ Infectiologie en Anesthesia-Reanimation: Outcome of postoperative pneumonia in the Eole study, Intensive Care Med 2003;29(2):179-88.
  • 11. Fagon JY, Chastre J: Nosocomial pneumonia, “Fink MP, Abraham E, Vincent J-L, Kochanek PM (eds): Textbook of Critical Care, Fifth ed.” kitabında p. 663-77, Elsevier Saunders, Philadelphia (2005).
  • 12. Fagon JY, Chastre J, Vaugnat A, Trouillet JL, Novara A, Gibert C: Nosocomial pneumonia and mortality among patients in intensive care units, JAMA 1996;275(11):866-9.
  • 13. Fagon JY, Chastre J, Wolff M et al: Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial, Ann Intern Med 2000;132(8):621-30.
  • 14. Gastmeier P, Sohr D, Geffers C, Behnke M, Rüden H: Risk factors for death due to nosocomial infection in intensive care unit patients: Findings from the Krankenhaus Infektions Surveillance System, Infect Control Hosp Epidemiol 2007;28(4):466-72.
  • 15. Greenaway CA, Embil J, Orr PH, McLeod J, Dyck B, Nicolle LE: Nosocomial pneumonia on general medical and surgical wards in a tertiary-care hospital, Infect Control Hosp Epidemiol 1997;18(11): 749-56.
  • 16. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group, Am J Respir Crit Care Med 1999; 159(4 Pt 1):1249-56.
  • 17. Kollef MH: Prevention of postoperative pneumonia, Hospital Physician 2007;64:47-60.
  • 18. Lawrence VA, Cornell JE, Smetana GW, American College of Physicians: Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians, Ann Intern Med 2006;144(8):596-608.
  • 19. Myrianthefs PM, Kalafati M, Samara I, Baltopoulos GJ: Nosocomial pneumonia, Crit Care Nurs Q 2004;27(3):241-57.
  • 20. Papazian L, Brefeon F, Thirion X et al: Effect of ventilator associated pneumonia on mortality and morbidity, Am J Respir Crit Care Med 1996; 154(1):91-7.
  • 21. Rello J, Jubert P, Valles J et al: Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996; 23(5):973-8.
  • 22. Ruiz M, Torres A, Ewig S et al: Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome, Am J Respir Crit Care Med 2000;162(1):119-25.
  • 23. Schein M, Yenumula PR, Genuit T: Postoperative pneumonia, Current Surgery 2002;59(6):540-8.
  • 24. Singh N, Falestiny MN, Rogers P et al: Pulmonary infiltrates in the surgical ICU: prospective assessment of predictors of etiology and mortality, Chest 1998;114(4):1129-36.
  • 25. Solé-Violán J, Fernandez JA, Benitez AB, Cardeñosa Cendrero JA, de Castro FR: Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia, Crit Care Med 2000;28(8):2737-41.
  • 26. Spencer RC: Predominant pathogens found in the European prevalence of infection in intensive care study, Eur J Clin Microbiol Infect Dis 1996;15(4): 281-5.
  • 27. Tejada Artigas A, Bello Dronda S, Chacón Vallés E et al: Risk factors for nosocomial pneumonia in critically ill trauma patients, Crit Care Med 2001;29(2):304-9.
  • 28. Trouillet JL, Chastre J, Vuagnat A et al: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria, Am J Respir Crit Care Med 1998;157(2):531-9.